Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) approved its New Drug Application (NDA) for OZEMPIC® (semaglutide)...
Read moreJohnson & Johnson announced that Janssen Vaccines & Prevention BV, part of the Janssen Pharmaceutical Companies, is working in partnership...
Read moreResearchers report creating a biologically accurate mass-production platform that overcomes major barriers to bioengineering human liver tissues suitable for therapeutic...
Read moreDNAtrix, a leader in the development of oncolytic virus immunotherapies for cancer, announced the intratumoral delivery of DNX-2401 to the...
Read moreBayer has extended its ongoing research collaboration with the Broad Institute of MIT and Harvard in the US by five...
Read moreAMPEL BioSolutions, a leading biomedical research firm based in Charlottesville, Va., Horizon Pharma plc and The Lupus Research Alliance today...
Read moreThe European Investment Bank (EIB) and Grifols signed an Euros 85 million loan to support the company's R+D+i initiatives focused...
Read moreSunovion Pharmaceuticals Inc announced that the U.S. Food and Drug Administration (FDA) approved the New Drug Application (NDA) for Lonhala™...
Read moreAstraZeneca has announced positive top-line results of the phase IV ASCENT trial for Tudorza Pressair (aclidinium bromide 400 µg, twice-daily),...
Read moreIntroducing a new disease-modifying therapy, from research through to launch, is an extremely complex process, with lengthy and expensive drug...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.